Mark Girardi has over 30 years of experience in life sciences, in vitro diagnostics, and medical devices commercialization and reimbursement. He has experience in sales, marketing, and strategy consulting. Most recently, Mark was Principal, Head of In Vitro/Medical Diagnostics at IQVIA.
Previously, Mark held roles as a Partner with Clarivate DRG, leading the firm’s MedTech practice area, and as Senior Vice President at Boston Healthcare Associates (Veranex). While at BHA, his focus was on the Medical Technology space working with clients in the medical device, diagnostics, and digital health areas. His area of specialization was supporting the commercialization of innovative technologies with a focus on global reimbursement, market access and commercialization advisory services.
Prior to this, Mark was with GfK Health (now Ipsos), a global consultancy and market research firm, where he was Senior Vice President responsible for the MedTech consulting practice. Before joining GfK, he spent five years at Predictive Biosciences as VP of Sales and Marketing. He also served as Senior Director of Marketing at Z-Tech Medical where he was responsible for commercialization of the company’s breast cancer screening devices. As Director of Marketing at Cytyc Corporation (now Hologic), he managed the worldwide launch of the Thin Prep Imaging System. He has also held senior marketing positions at Genzyme Genetics and Millipore.